ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.
Nalee KimSe Hoon KimSeok-Gu KangJu Hyung MoonJaeho ChoChang-Ok SuhHong In YoonJong Hee ChangPublished in: Radiation oncology (London, England) (2020)
Our results demonstrated that ATM mutations might be involved in the increased radio-sensitivity with excellent in-field control despite the aggressive nature of IDH-wildtype high-grade glioma. Further studies are necessary to uncover the potential role of ATM as a biomarker and candidate therapeutic target in high-grade gliomas.